| 0.9303 0.03 (3.37%) | 04-27 10:58 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.26 | 1-year : | 1.39 |
| Resists | First : | 1.08 | Second : | 1.19 |
| Pivot price | 0.97  |
|||
| Supports | First : | 0.89 | Second : | 0.74 |
| MAs | MA(5) : | 0.92 |
MA(20) : | 0.97 |
| MA(100) : | 0.97 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 5.5 |
D(3) : | 8.1 |
| RSI | RSI(14): 41.3  |
|||
| 52-week | High : | 1.75 | Low : | 0.56 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ALPS ] has closed above bottom band by 15.2%. Bollinger Bands are 43.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for {EMPTY} bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.93 - 0.94 | 0.94 - 0.94 |
| Low: | 0.89 - 0.89 | 0.89 - 0.9 |
| Close: | 0.89 - 0.9 | 0.9 - 0.91 |
Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predictive, preventive, and precision medicine.
Mon, 20 Apr 2026
Director Lee Hee Hang reports 20,000 ALPS shares in initial Form 3 - Stock Titan
Fri, 17 Apr 2026
Alps Group Adds Former EY Partner Hee H. Lee to Board to Bolster Governance - TipRanks
Fri, 17 Apr 2026
Alps Group appoints Hee H. Lee to board of directors - Investing.com
Fri, 17 Apr 2026
Board grows to 6 as Alps Group taps ex-EY partner Hee Lee - Stock Titan
Thu, 08 Jan 2026
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer - GlobeNewswire
Fri, 12 Dec 2025
Alps Group Inc (NASDAQ:ALPS) CEO Seng Tham's holdings dropped 12% in value as a result of the recent pullback - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|